• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

射血分数保留的心力衰竭患者心脏结构和功能的种族差异

Racial Differences of Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction.

作者信息

Sorimachi Hidemi, Obokata Masaru, Omote Kazunori, Reddy Yogesh N V, Burkhoff Daniel, Shah Sanjiv J, Borlaug Barry A

机构信息

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota; Department of Cardiovascular Medicine, Gunma University Graduate School of Medicine, Maebashi, Japan.

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota; Department of Cardiovascular Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

出版信息

J Card Fail. 2025 Apr;31(4):624-634. doi: 10.1016/j.cardfail.2024.08.042. Epub 2024 Aug 23.

DOI:10.1016/j.cardfail.2024.08.042
PMID:39182824
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11846961/
Abstract

BACKGROUND

Potential race differences in cardiac structure and function among patients with heart failure with preserved ejection fraction (HFpEF) are not well-understood, but may have pathophysiological and treatment implications.

METHODS AND RESULTS

In this study, patients with HFpEF who self-identified as Asian (n = 360), White (n = 787), and Black (n = 171) from 3 institutions underwent comprehensive transthoracic echocardiography to evaluate for potential differences. The Asian HFpEF group was oldest and the Black HFpEF group was youngest (75 ± 12 years vs 73 ± 13 years vs 62 ± 12 years; P < .0001). Women constituted the lowest proportion of patients with HFpEF among Asian individuals, but were the largest among Black patients (49% vs 56% vs 73%; P < .0001). Body mass index and obesity prevalence were highest in Black patients with HFpEF and were lowest in Asian patients. Black individuals with HFpEF had greater left ventricular (LV) wall thickening and concentricity, smaller LV chamber size, leftward-shifted LV end-diastolic pressure-volume relationship, indicating greater LV stiffening, smallest left atrial volumes, and the most right ventricular dilatation. Asian individuals with HFpEF had greater LV and left atrial dilation, more rightward shifted LV end-diastolic pressure-volume relationship, and the highest arterial stiffness.

CONCLUSIONS

In summary, we show that patients with HFpEF of Asian, Black, and White race display key differences in clinical, anthropometric, and cardiac structure-function indices, indicating that consideration of race-related differences might important to individualize treatment strategies in HFpEF.

摘要

背景

射血分数保留的心力衰竭(HFpEF)患者中心脏结构和功能的潜在种族差异尚未得到充分理解,但可能具有病理生理学和治疗意义。

方法与结果

在本研究中,来自3家机构的自我认定为亚洲人(n = 360)、白人(n = 787)和黑人(n = 171)的HFpEF患者接受了全面的经胸超声心动图检查,以评估潜在差异。亚洲HFpEF组年龄最大,黑人HFpEF组年龄最小(75±12岁 vs 73±13岁 vs 62±12岁;P <.0001)。亚洲HFpEF患者中女性所占比例最低,但在黑人患者中女性比例最高(49% vs 56% vs 73%;P <.0001)。黑人HFpEF患者的体重指数和肥胖患病率最高,而亚洲患者最低。患有HFpEF的黑人左心室(LV)壁增厚和向心性更强,左心室腔尺寸更小,左心室舒张末期压力-容积关系向左移位,表明左心室僵硬度更大,左心房容积最小,右心室扩张最明显。患有HFpEF的亚洲人左心室和左心房扩张更明显,左心室舒张末期压力-容积关系向右移位更多,且动脉僵硬度最高。

结论

总之,我们表明亚洲、黑人和白人种族的HFpEF患者在临床、人体测量和心脏结构功能指标上存在关键差异,这表明考虑种族相关差异可能对HFpEF的个体化治疗策略很重要。

相似文献

1
Racial Differences of Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction.射血分数保留的心力衰竭患者心脏结构和功能的种族差异
J Card Fail. 2025 Apr;31(4):624-634. doi: 10.1016/j.cardfail.2024.08.042. Epub 2024 Aug 23.
2
Race-ethnic and sex differences in left ventricular structure and function: the Coronary Artery Risk Development in Young Adults (CARDIA) Study.青年成人冠状动脉风险发展研究(CARDIA研究)中左心室结构和功能的种族-民族及性别差异
J Am Heart Assoc. 2015 Mar 13;4(3):e001264. doi: 10.1161/JAHA.114.001264.
3
Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.心力衰竭伴左心室射血分数保留患者的超声心动图特征。
J Am Coll Cardiol. 2019 Dec 10;74(23):2858-2873. doi: 10.1016/j.jacc.2019.09.063.
4
Ventricular stiffening and chamber contracture in heart failure with higher ejection fraction.射血分数较高的心衰患者的心室僵硬和心腔收缩。
Eur J Heart Fail. 2023 May;25(5):657-668. doi: 10.1002/ejhf.2843. Epub 2023 Apr 12.
5
Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.应变成像技术评估射血分数保留心力衰竭患者的收缩功能障碍。
J Am Coll Cardiol. 2014 Feb 11;63(5):447-56. doi: 10.1016/j.jacc.2013.09.052. Epub 2013 Oct 30.
6
Left Ventricular Elastance With Resting Volumetric Transthoracic Echocardiography Identifies Different Phenotypes in Heart Failure With Preserved Ejection Fraction: A Retrospective Analysis of a Multicenter Prospective Observational Study.静息容积经胸超声心动图测定的左心室弹性可识别射血分数保留的心力衰竭的不同表型:一项多中心前瞻性观察研究的回顾性分析
J Am Soc Echocardiogr. 2025 May;38(5):409-420. doi: 10.1016/j.echo.2024.12.012. Epub 2025 Jan 14.
7
Racial Differences in Age-Related Changes in Left Ventricular Structural and Functional Echocardiographic Measurements Among Healthy Japanese and American Participants - A Subanalysis of the World Alliance Society of Echocardiography Normal Values Study.健康日美参与者左心室结构和功能超声心动图测量的年龄相关变化中的种族差异 - 世界超声心动图联盟正常数值研究的亚分析。
Circ J. 2024 Aug 23;88(9):1461-1471. doi: 10.1253/circj.CJ-24-0031. Epub 2024 Jun 7.
8
Prognostic importance of pathophysiologic markers in patients with heart failure and preserved ejection fraction.心力衰竭伴射血分数保留患者病理生理标志物的预后意义。
Circ Heart Fail. 2014 Mar 1;7(2):288-99. doi: 10.1161/CIRCHEARTFAILURE.113.000854. Epub 2013 Dec 23.
9
Functional iron deficiency and diastolic function in heart failure with preserved ejection fraction.射血分数保留的心力衰竭中的功能性缺铁与舒张功能
Int J Cardiol. 2013 Oct 12;168(5):4652-7. doi: 10.1016/j.ijcard.2013.07.185. Epub 2013 Jul 30.
10
Evaluation of left ventricular diastolic function profile in patients with pulmonary hypertension due to heart failure with preserved ejection fraction.射血分数保留的心力衰竭所致肺动脉高压患者左心室舒张功能特征的评估
Clin Cardiol. 2017 Jun;40(6):356-363. doi: 10.1002/clc.22664. Epub 2016 Dec 27.

引用本文的文献

1
Current Status of Cardiovascular Disease in Asian Americans: One Size Does Not Fit All.亚裔美国人心血管疾病的现状:一刀切并不适用。
Curr Cardiol Rep. 2025 Jun 17;27(1):94. doi: 10.1007/s11886-025-02245-4.

本文引用的文献

1
Characteristics of heart failure with a preserved ejection fraction in black South African patients.南非黑人射血分数保留的心力衰竭患者的特征
Int J Cardiol Heart Vasc. 2024 Apr 11;52:101408. doi: 10.1016/j.ijcha.2024.101408. eCollection 2024 Jun.
2
Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial.司美格鲁肽在肥胖症分级和体重减轻的 HFpEF 中的应用:STEP-HFpEF 试验的预设分析。
Nat Med. 2023 Sep;29(9):2358-2365. doi: 10.1038/s41591-023-02526-x. Epub 2023 Aug 27.
3
Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity.司美格鲁肽治疗射血分数保留的心力衰竭合并肥胖患者的疗效。
N Engl J Med. 2023 Sep 21;389(12):1069-1084. doi: 10.1056/NEJMoa2306963. Epub 2023 Aug 25.
4
Cardiac and Metabolic Effects of Dapagliflozin in Heart Failure With Preserved Ejection Fraction: The CAMEO-DAPA Trial.达格列净对射血分数保留的心力衰竭的心脏和代谢影响:CAMEO-DAPA 试验。
Circulation. 2023 Sep 5;148(10):834-844. doi: 10.1161/CIRCULATIONAHA.123.065134. Epub 2023 Aug 3.
5
Epidemiology, Pathophysiology, Diagnosis, and Therapy of Heart Failure With Preserved Ejection Fraction in Japan.日本射血分数保留型心力衰竭的流行病学、病理生理学、诊断和治疗。
J Card Fail. 2023 Mar;29(3):375-388. doi: 10.1016/j.cardfail.2022.09.018. Epub 2023 Mar 14.
6
Heart Failure With Preserved Ejection Fraction: JACC Scientific Statement.射血分数保留的心力衰竭:美国心脏病学会杂志科学声明。
J Am Coll Cardiol. 2023 May 9;81(18):1810-1834. doi: 10.1016/j.jacc.2023.01.049. Epub 2023 Apr 19.
7
Heart Failure With Preserved Ejection Fraction: A Review.射血分数保留的心力衰竭:综述。
JAMA. 2023 Mar 14;329(10):827-838. doi: 10.1001/jama.2023.2020.
8
Phenomapping in heart failure with preserved ejection fraction: insights, limitations, and future directions.射血分数保留型心力衰竭的表型映射:见解、局限性和未来方向。
Cardiovasc Res. 2023 Feb 3;118(18):3403-3415. doi: 10.1093/cvr/cvac179.
9
Dapagliflozin for heart failure according to body mass index: the DELIVER trial.达格列净治疗心力衰竭与体重指数的相关性:DELIVER 试验。
Eur Heart J. 2022 Nov 1;43(41):4406-4417. doi: 10.1093/eurheartj/ehac481.
10
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.达格列净治疗射血分数轻度降低或保留的心力衰竭。
N Engl J Med. 2022 Sep 22;387(12):1089-1098. doi: 10.1056/NEJMoa2206286. Epub 2022 Aug 27.